Remineralization Potential of Bioactive Varnish
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
This randomized controlled trial is held to investigate the effectiveness of two remineralizing agents surface pre-reacted glass-ionomer (S-PRG) filler and fluoride in management of white spot lesions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 16, 2026
CompletedFirst Posted
Study publicly available on registry
May 22, 2026
CompletedStudy Start
First participant enrolled
June 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
Study Completion
Last participant's last visit for all outcomes
December 1, 2026
May 22, 2026
May 1, 2026
6 months
May 16, 2026
May 16, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Patients tooth caries lesion state
FDI Criteria (Visual examination of active caries lesion)
6 months
Secondary Outcomes (1)
Patients' tooth color change
6 months
Study Arms (2)
S-PRG barrier coat
EXPERIMENTALvarnish containing Surface pre-reacted glass-ionomer technology
Profluorid Varnish
ACTIVE COMPARATORFluoride varnish
Interventions
varnish containing Surface pre-reacted glass-ionomer technology
Eligibility Criteria
You may qualify if:
- Patients within 16-35 years of age.
- Each patient has 4 or more WSLs
- Mild and moderate WSLs.
- Good oral hygiene and willing patients who can attend study visits.
- Symmetrical number of permanent teeth in each arch (mesial to second molars).
You may not qualify if:
- Active carious lesions.
- Labial surface restorations.
- Intrinsic and extrinsic stains.
- Patients who have a significant medical history or if they are smokers.
- Patients who participated in clinical study during the preceding six months of the start of this trial.
- Criteria for discontinuation; Mortality and acquiring severe debilitating disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Master's degree Student
Study Record Dates
First Submitted
May 16, 2026
First Posted
May 22, 2026
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
May 22, 2026
Record last verified: 2026-05